Ruth Peters1,2,3, Kaarin J Anstey1,2, Andrew Booth4, Nigel Beckett5, Jane Warwick6, Riitta Antikainen7,8, Kenneth Rockwood9, Jean Peters4, Christopher J Bulpitt10. 1. Neuroscience Research Australia (NeuRA), Barker Street, Randwick, Australia. 2. School of Psychology, University of New South Wales, Sydney, Australia. 3. School of Public Health, Imperial College London, London, UK. 4. School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK. 5. Guys and St Thomas' NHS Foundation Trust, London, UK. 6. Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. 7. Center for Life Course Health Research/Geriatrics, Faculty of Medicine, University of Oulu, Oulu, Finland. 8. Medical Research Center Oulu, Oulu University Hospital, Oulu City Hospital, Oulu, Finland. 9. Division of Geriatric Medicine, Dalhousie University, Veteran's Memorial Lane, Halifax, Nova Scotia, Canada. 10. Care of the Elderly, Imperial College London, London, UK.
Abstract
Aims: Systematically reviewing the literature found orthostatic hypotension (OH) to be associated with an increased risk of incident dementia but limited data were available in those at highest risk, the hypertensive oldest-old. Our aim was to analyse the relationship between OH and incident cognitive decline or dementia in this group and to synthesize the evidence base overall. Method and results: Participants aged ≥80 years, with hypertension, were from the Hypertension in the Very Elderly Trial (HYVET) cohort. Orthostatic hypotension was defined as a fall of ≥15 mmHg in systolic and or ≥7 mmHg in diastolic pressure after 2 min standing from a sitting position. Subclinical orthostatic hypotension with symptoms (SOH) was defined as a fall <OH but with unsteadiness, light-headedness, or faintness in the week before blood pressure measurement. Proportional hazard regression was used to examine the relationship between baseline OH, SOH, and cognitive outcomes. There were 3121 in the analytical sample, 538 with OH. Orthostatic hypotension was associated with increased risk of cognitive decline (906 events), hazard ratio (HR) 1.36 (95% confidence interval 1.14-1.59). For incident dementia (241 events), HR 1.34 (0.98-1.84). When competing risk of cardiovascular events were taken into account results were HR 1.39 (1.19-1.62) and HR 1.34 (1.05-1.73), respectively. Subclinical orthostatic hypotension was associated with an increased risk of cognitive decline HR 1.56 (1.12-2.17) and dementia HR 1.79 (1.00-3.20). Combining the results from the HYVET cohort in a meta-analysis with the existing published literature in this area found a 21% (9-35%) increased risk of dementia with OH. Conclusion: Orthostatic hypotension indicates an increased risk of dementia and cognitive decline. SOH may also be considered a risk factor, at least in older hypertensive adults. Questions remain regarding the mechanisms and whether interventions to reduce impact of OH could protect cognition.
Aims: Systematically reviewing the literature found orthostatic hypotension (OH) to be associated with an increased risk of incident dementia but limited data were available in those at highest risk, the hypertensive oldest-old. Our aim was to analyse the relationship between OH and incident cognitive decline or dementia in this group and to synthesize the evidence base overall. Method and results: Participants aged ≥80 years, with hypertension, were from the Hypertension in the Very Elderly Trial (HYVET) cohort. Orthostatic hypotension was defined as a fall of ≥15 mmHg in systolic and or ≥7 mmHg in diastolic pressure after 2 min standing from a sitting position. Subclinical orthostatic hypotension with symptoms (SOH) was defined as a fall <OH but with unsteadiness, light-headedness, or faintness in the week before blood pressure measurement. Proportional hazard regression was used to examine the relationship between baseline OH, SOH, and cognitive outcomes. There were 3121 in the analytical sample, 538 with OH. Orthostatic hypotension was associated with increased risk of cognitive decline (906 events), hazard ratio (HR) 1.36 (95% confidence interval 1.14-1.59). For incident dementia (241 events), HR 1.34 (0.98-1.84). When competing risk of cardiovascular events were taken into account results were HR 1.39 (1.19-1.62) and HR 1.34 (1.05-1.73), respectively. Subclinical orthostatic hypotension was associated with an increased risk of cognitive decline HR 1.56 (1.12-2.17) and dementia HR 1.79 (1.00-3.20). Combining the results from the HYVET cohort in a meta-analysis with the existing published literature in this area found a 21% (9-35%) increased risk of dementia with OH. Conclusion:Orthostatic hypotension indicates an increased risk of dementia and cognitive decline. SOH may also be considered a risk factor, at least in older hypertensive adults. Questions remain regarding the mechanisms and whether interventions to reduce impact of OH could protect cognition.
Authors: Lawrence C Perlmuter; Garima Sarda; Vanessa Casavant; Kimberly O'Hara; Mariah Hindes; Patrick T Knott; Aron D Mosnaim Journal: Clin Auton Res Date: 2011-09-25 Impact factor: 4.435
Authors: Justine E F Moonen; Jessica C Foster-Dingley; Wouter de Ruijter; Jeroen van der Grond; Anton J M de Craen; Roos C van der Mast Journal: Age Ageing Date: 2016-01-11 Impact factor: 10.668
Authors: Win-Kuang Shen; Robert S Sheldon; David G Benditt; Mitchell I Cohen; Daniel E Forman; Zachary D Goldberger; Blair P Grubb; Mohamed H Hamdan; Andrew D Krahn; Mark S Link; Brian Olshansky; Satish R Raj; Roopinder Kaur Sandhu; Dan Sorajja; Benjamin C Sun; Clyde W Yancy Journal: Circulation Date: 2017-03-09 Impact factor: 29.690
Authors: Brett H Shaw; Emily M Garland; Bonnie K Black; Sachin Y Paranjape; Cyndya A Shibao; Luis E Okamoto; Alfredo Gamboa; André Diedrich; W Dale Plummer; William D Dupont; Italo Biaggioni; David Robertson; Satish R Raj Journal: J Hypertens Date: 2017-05 Impact factor: 4.844
Authors: Ruth Peters; Nigel Beckett; Francoise Forette; Jaakko Tuomilehto; Robert Clarke; Craig Ritchie; Adam Waldman; Ivan Walton; Ruth Poulter; Shuping Ma; Marius Comsa; Lisa Burch; Astrid Fletcher; Christopher Bulpitt Journal: Lancet Neurol Date: 2008-07-07 Impact factor: 44.182
Authors: Hsu-Ko Kuo; Farzaneh Sorond; Ikechukwu Iloputaife; Margaret Gagnon; William Milberg; Lewis A Lipsitz Journal: J Gerontol A Biol Sci Med Sci Date: 2004-11 Impact factor: 6.053
Authors: Stephen P Juraschek; Addison A Taylor; Jackson T Wright; Gregory W Evans; Edgar R Miller; Timothy B Plante; William C Cushman; Tanya R Gure; William E Haley; Imran Moinuddin; John Nord; Suzanne Oparil; Carolyn Pedley; Christianne L Roumie; Jeff Whittle; Alan Wiggers; Ciarán Finucane; Rose Anne Kenny; Lawrence J Appel; Raymond R Townsend Journal: Hypertension Date: 2020-01-27 Impact factor: 10.190
Authors: Jan Willem van Dalen; Henri Jmm Mutsaerts; Jan Petr; Matthan Wa Caan; Eric P Moll van Charante; Bradley J MacIntosh; Willem A van Gool; Aart J Nederveen; Edo Richard Journal: J Cereb Blood Flow Metab Date: 2020-12-16 Impact factor: 6.200
Authors: Andrew D Robertson; Sean J Udow; Alberto J Espay; Aristide Merola; Richard Camicioli; Anthony E Lang; Mario Masellis Journal: Neuropsychiatr Dis Treat Date: 2019-08-02 Impact factor: 2.570
Authors: William J Kostis; Davit Sargsyan; Choukri Mekkaoui; Abel E Moreyra; Javier Cabrera; Nora M Cosgrove; Jeanine E Sedjro; John B Kostis; William C Cushman; John S Pantazopoulos; Sara L Pressel; Barry R Davis Journal: J Hum Hypertens Date: 2019-02-25 Impact factor: 3.012